Search
aggrecan core protein; cartilage-specific proteoglycan core protein; CSPCP; chondroitin sulfate proteoglycan core protein 1; contains: aggrecan core protein 2 (ACAN, AGC1, CSPG1, MSK16)
Function:
- major component of extracellular matrix of cartilage
- role in resisting compression in cartilage
- binds avidly to hyaluronic acid via an N-terminal globular region
- contains mostly chondroitin sulfate, but also keratan sulfate chains, N-linked & O-linked oligosaccharides
- interacts with FBLN1 (putative)
Structure:
- two globular domains, G1 & G2, comprise the N-terminus of the proteoglycan, while another globular region, G3, makes up the C-terminus.
- G1 contains link domains & thus consists of three disulfide- bonded loop structures designated as the A, B, B' motifs.
- G2 is similar to G1
- the keratan sulfate (KS) & the chondroitin sulfate (CS) attachment domains lie between G2 & G3 belongs to the aggrecan/versican proteoglycan family
- contains 1 C-type lectin domain
- contains 1 EGF-like domain
- contains 1 Ig-like V-type domain (immunoglobulin-like)
- contains 4 link domains
- contains 1 Sushi (CCP/SCR) domain
Compartment:
- secreted, extracellular space, extracellular matrix (putative)
Alternative splicing: named isoforms=3; Additional isoforms seem to exist
Expression:
- restricted to cartilages
- detected in chondrocytes throughout the developing skeleton
Pathology:
- defects in ACAN are the cause of spondyloepiphyseal dysplasia type Kimberley
- release of aggrecan fragments from articular cartilage into the synovial fluid at all stages of human osteoarthritis is the result of cleavage by aggrecanase [2,3]
General
matrix protein
proteoglycan core protein
Properties
SIZE: entity length = 2415 aa
MW = 250 kD
COMPARTMENT: extracellular matrix
MOTIF: signal sequence {1-16}
immunoglobulin superfamily domain {34-147}
MOTIF: G1-A {48-141}
cysteine residue {C51}
MODIFICATION: cysteine residue {C133}
N-glycosylation site {N126}
cysteine residue {C133}
MODIFICATION: cysteine residue {C51}
G1-B {152-247}
Link {153-248} (4)
MOTIF: cysteine residue {C175}
MODIFICATION: cysteine residue {C246}
cysteine residue {C199}
MODIFICATION: cysteine residue {C220}
cysteine residue {C220}
MODIFICATION: cysteine residue {C199}
N-glycosylation site {N239}
cysteine residue {C246}
MODIFICATION: cysteine residue {C175}
G1-B' {253-349}
Thr glycosylation site {T371}
Thr glycosylation site {T376}
N-glycosylation site {N387}
peptide motif {392-393}
N-glycosylation site {N434}
G2-B {477-571}
G2-B' {578-672}
KS {676-848}
MOTIF: N-glycosylation site {N737}
12 X 6 AA approximate tandem repeats of
E-[GVE]-P-[SFY]-[APT]-[TSP] {772-843} (12)
CS-1 {851-1497}
CS-2 {1498-2162}
MOTIF: N-glycosylation site {N1898}
EGF domain {2164-2199}
MOTIF: cysteine residue {C2168}
MODIFICATION: cysteine residue {C2178}
cysteine residue {C2173}
MODIFICATION: cysteine residue {C2187}
cysteine residue {C2178}
MODIFICATION: cysteine residue {C2168}
cysteine residue {C2187}
MODIFICATION: cysteine residue {C2173}
cysteine residue {C2189}
MODIFICATION: cysteine residue {C2198}
cysteine residue {C2198}
MODIFICATION: cysteine residue {C2189}
carbohydrate-recognition domain {2201-2327}
MOTIF: cysteine residue {*1} (3)
MODIFICATION: cysteine residue {*2}
cysteine residue {*2} (3)
MODIFICATION: cysteine residue {*1}
cysteine residue {C2205}
MODIFICATION: cysteine residue {C2216}
cysteine residue {C2216}
MODIFICATION: cysteine residue {C2205}
cysteine residue {C2233}
MODIFICATION: cysteine residue {C2325}
cysteine residue {C2301}
MODIFICATION: cysteine residue {C2317}
cysteine residue {C2317}
MODIFICATION: cysteine residue {C2301}
cysteine residue {C2325}
MODIFICATION: cysteine residue {C2233}
Sushi domain {2330-2390}
MOTIF: cysteine residue {C2332}
MODIFICATION: cysteine residue {C2375}
cysteine residue {C2361}
MODIFICATION: cysteine residue {C2388}
cysteine residue {C2375}
MODIFICATION: cysteine residue {C2332}
cysteine residue {C2388}
MODIFICATION: cysteine residue {C2361}
Database Correlations
OMIM correlations
UniProt P16112
PFAM correlations
References
- Ruoslahti E, Yamaguchi Y.
Proteoglycans as modulators of growth factor activities.
Cell. 1991 Mar 8;64(5):867-9. Review.
PMID: 2001586
- UniProt :accession P16112
- Journal Watch 25(10):81, 2005
Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL,
Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA.
Deletion of active ADAMTS5 prevents cartilage degradation in
a murine model of osteoarthritis.
Nature. 2005 Mar 31;434(7033):644-8.
PMID: 15800624
- Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE,
Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, Fourie AM,
Fosang AJ.
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo
and in vitro.
Nature. 2005 Mar 31;434(7033):648-52.
PMID: 15800625
- Functional glycomics gateway - glycan binding Note: Aggrecan
http://www.functionalglycomics.org/glycomics/GBPServlet?&operationtype=view&cbpId=cbp_hum_Ctlect_351